Generex Biotechnology Awarded New Drug Delivery Patent
Company Expands Australian Patent Portfolio
"We are pleased to include this latest patent to our expanding portfolio," said Rose Perri, the Company's Chief Operating Officer. "While we continue to move forward with the regulatory process in major markets, we continue to work on patent submissions for other jurisdictions."
Generex currently holds an aggregate of 128 patents worldwide (21 of which are United States Patents) and has an aggregate of 134 patent applications pending in various jurisdictions.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.